• Login
    View Item 
    •   Home
    • Research, Student
    • Monroe F. Swilley, Jr. Student Research Award
    • 2014 Winners
    • View Item
    •   Home
    • Research, Student
    • Monroe F. Swilley, Jr. Student Research Award
    • 2014 Winners
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MercerCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    About URSA

    Collecting PolicyLicense AgreementDigitization SpecificationsRemoval Policy

    Statistics

    Display statistics

    A Review of Withdraw Strategies for Discontinuing Antiepileptic Therapy in Epilepsy and Pain Management

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Review of Withdraw Strategies.pdf
    Size:
    184.7Kb
    Format:
    PDF
    Description:
    A Review of Withdraw Strategies...
    Download
    Thumbnail
    Name:
    Reflection Statement — Williams.pdf
    Size:
    22.81Kb
    Format:
    PDF
    Description:
    Williams Reflection Statement
    Download
    Average rating
     
       votes
    Cast your vote
    You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.
    Star rating
     
    Your vote was cast
    Thank you for your feedback
    Author
    Williams, Jessica
    Keyword
    Antiepileptic drugs
    withdrawal
    tapering strategies
    off-label use
    pain management
    
    Metadata
    Show full item record
    URI
    http://hdl.handle.net/10898/2845
    Title
    A Review of Withdraw Strategies for Discontinuing Antiepileptic Therapy in Epilepsy and Pain Management
    Abstract
    Purpose: Pain management is complicated by unacceptable levels of opioid abuse with few safe alternatives. The need exists for analgesic agents with limited abuse potential and recommendations for their safe use. Since the 1960’s, antiepileptic drugs have been used as adjunctively in pain management. By virtue of their pharmacokinetic and risk profiles, antiepileptic drugs require more prescriber surveillance compared to other medications. However, there is no standard approach for discontinuing these drugs. The objectives of this review were to summarize the risk profile of tapering antiepileptic drugs used for epilepsy vs. pain management and to identify best practices for safe tapering. Methods: A retrospective review was performed of literature addressing discontinuation of antiepileptic drugs. Articles were collected from PubMed and Ovid using keywords: anticonvulsant, antiepileptic, withholding treatment, taper and withdrawal. The limitations included English language only publications, regardless of country of origin, and publication between 1990 and 2013. Results: Findings revealed 25 published randomized controlled trials, reviews, case reports and editorials. While no taper guideline was found, many studies used a gradual taper protocol ranging from one month to more than four years for discontinuation. However no consistency was found between protocols. Risks for continuation and inappropriate discontinuation of antiepileptic therapy were aggregated from FDA labeled information and published case reports. This constituted the risk profile. Risks of acute discontinuation in epilepsy and pain management manifest differently. In epilepsy, documentation of acute discontinuation of AEDs results in recurrence of epileptic episode. Tapering therapy to discontinuation in epilepsy results in a higher risk of seizure recurrence in the first six months of withdrawal compared to patients continuing therapy. In pain management, acute discontinuation of AEDs results in a benzodiazepine-like withdrawal syndrome with symptoms such as diaphoresis, agitation and altered mental status. However unlike true benzodiazepine withdrawal, acute discontinuation of AEDs in pain management is unresolved by benzodiazepine administration. Conclusion: Tapering antiepileptic drugs when discontinuing therapy in epilepsy is common practice though there is no standard taper regimen documented consistently throughout the literature. Tapering strategies for discontinuing antiepileptic therapy when used in pain management are not well documented. This review identifies gaps in the literature concerning safe discontinuation of antiepileptic drugs used both for the primary indication as well as pain management. Clinical pharmacists would be greatly benefited by future research into appropriate regimens for tapering patients off of antiepileptic therapy with consideration of the effect removing antiepileptics from the body would have on other drug therapies the patient continues.
    Description
    Monroe F. Swilley, Jr. Student Research Award — First Prize
    Collections
    2014 Winners

    entitlement

     

    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.